XCUR Company Profile and Key Details
NASDAQ : XCUR
Exicure
$4.43
-0.11-2.42%
At Close 4:00 PM62.95
BESG ScoreESG Rating
Price Chart
Stock Price Today
Exicure, Inc. (XCUR) stock declined over -2.42%, trading at $4.43 on NASDAQ, down from the previous close of $4.54. The stock opened at $4.50, fluctuating between $4.34 and $4.66 in the recent session.
Stock Snapshot
4.54
Prev. Close
28.24M
Market Cap
4.34
Day Low
-1.19
P/E Ratio
-3.72
EPS (TTM)
-1.83
Cash Flow per Share
4.5
Open
6.37M
Number of Shares
4.66
Day High
29.19%
Free Float in %
1.15
Book Value
21.1K
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 18, 2026 | 4.46 | 4.65 | 4.34 | 4.43 | 21.1K |
| Mar 17, 2026 | 4.80 | 4.85 | 4.50 | 4.54 | 27.97K |
| Mar 16, 2026 | 4.26 | 4.88 | 4.24 | 4.58 | 71.61K |
| Mar 13, 2026 | 4.15 | 4.26 | 3.99 | 4.20 | 26.46K |
| Mar 12, 2026 | 3.95 | 4.10 | 3.94 | 3.94 | 5K |
| Mar 11, 2026 | 3.98 | 4.13 | 3.90 | 4.13 | 17.52K |
| Mar 10, 2026 | 4.09 | 4.15 | 3.89 | 4.12 | 23.1K |
| Mar 09, 2026 | 4.02 | 4.17 | 4.00 | 4.09 | 6.22K |
| Mar 06, 2026 | 4.25 | 4.26 | 4.03 | 4.15 | 6.94K |
| Mar 03, 2026 | 3.66 | 3.70 | 3.53 | 3.55 | 10.28K |
| Mar 02, 2026 | 3.62 | 3.87 | 3.62 | 3.62 | 7.79K |
| Feb 27, 2026 | 3.63 | 3.81 | 3.63 | 3.74 | 7.88K |
| Feb 26, 2026 | 3.63 | 3.82 | 3.60 | 3.71 | 15.75K |
| Feb 25, 2026 | 3.60 | 3.79 | 3.58 | 3.79 | 27.46K |
| Feb 24, 2026 | 3.65 | 3.65 | 3.59 | 3.59 | 10.48K |
| Feb 23, 2026 | 3.83 | 3.84 | 3.62 | 3.62 | 5.73K |
| Feb 20, 2026 | 3.68 | 4.00 | 3.58 | 3.58 | 16.92K |
| Feb 19, 2026 | 3.64 | 3.76 | 3.53 | 3.57 | 26.92K |
| Feb 18, 2026 | 3.79 | 3.89 | 3.50 | 3.66 | 36.47K |
| Feb 17, 2026 | 4.18 | 4.25 | 3.82 | 3.89 | 32.71K |
Contact Details
About Company
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Company Information
| Employees | 7 |
| Beta | 4.19 |
| Sales or Revenue | $28.83M |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Stock Peers
REGN
-14.93-1.97%
Regeneron Pharmaceuticals, Inc.$744.12ARGX-21.26-3.01%
argenx SE$684.77UTHR-9.67-1.79%
United Therapeutics Corporation$530.35VRTX-10.9-2.36%
Vertex Pharmaceuticals Incorporated$451.59MDGL-1.18-0.27%
Madrigal Pharmaceuticals, Inc.$442.00KRTX0.09+0.03%
Karuna Therapeutics, Inc.$329.83ALNY-5.62-1.75%
Alnylam Pharmaceuticals, Inc.$314.80PRAX-14.59-4.81%
Praxis Precision Medicines, Inc.$288.79KRYS-5.5-2.15%
Krystal Biotech, Inc.$250.83SGEN-0.16-0.07%
Seagen Inc.$228.74Technical Performance
XCUR has shown sold momentum, gaining 5.14% over the past week and 35.24% over the past quarter, though year-to-date performance is up 13.28%. Short-term trend indicators are bullishly aligned (SMA20 -6.95%, SMA50 -26.69%, SMA200 -37.81%). The stock’s 14-day RSI is 35.9 (weak momentum), while the ATR of 0.34 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -76.68% below its high and over 19.65% above its low. Average 10-day trading volume of 24.87 thousand shares is below the 3-month average of 38.31 thousand, indicating normal recent market interest.
Earnings & Analyst Outlook
Exicure, Inc. generated EPS of -$1.50 over the past year. Five-year average earnings growth is 41.35%. Exicure, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 15, 2022, missed forecasts by 38.33%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include 7.69% in May 12, 2021.
Shareholding & Insider Activity
Exicure, Inc. has 6.32 million shares outstanding. The public float is 2.33 million shares, elevated short interest at 0.53% of float. This equals 30.20 thousand shares. The short ratio is 0.46 days. Institutional investors hold 16.45% of the float. Insiders own 62.59%. AURASENSE LLC holds 11.26 million shares, Mirkin Chad A. has 11.26 million shares and Muralidhar Bali has 8.45 million shares. Over the past six months, insider transactions show net selling. They sold 2.17 million shares across 4 transactions.
Frequently Asked Questions
What is the current Exicure, Inc. (XCUR) stock price?
Exicure, Inc. (NASDAQ: XCUR) stock price is $4.43 in the last trading session. During the trading session, XCUR stock reached the peak price of $4.66 while $4.34 was the lowest point it dropped to. The percentage change in XCUR stock occurred in the recent session was -2.42% while the dollar amount for the price change in XCUR stock was - $0.11.
XCUR's industry and sector of operation?
The NASDAQ listed XCUR is part of Biotechnology industry that operates in the broader Healthcare sector. Exicure, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of XCUR?
Ms. Sarah Longoria
Chief HR & Compliance Officer
Mr. Bart Anderson
Senior Director of R&D
Dr. Matthias G. Schroff Ph.D.
Chief Executive Officer, Pres & Director
Mr. Joshua Miller
Chief Accounting Officer
Mr. Jung-Sang Kim
Chief Executive Officer, Chief Financial Officer & Director
Mr. Elias D. Papadimas
Chief Financial Officer & Corporation Sec.
Chief HR & Compliance Officer
Mr. Bart Anderson
Senior Director of R&D
Dr. Matthias G. Schroff Ph.D.
Chief Executive Officer, Pres & Director
Mr. Joshua Miller
Chief Accounting Officer
Mr. Jung-Sang Kim
Chief Executive Officer, Chief Financial Officer & Director
Mr. Elias D. Papadimas
Chief Financial Officer & Corporation Sec.
How XCUR did perform over past 52-week?
XCUR's closing price is 42.86% higher than its 52-week low of $3.10 where as its distance from 52-week high of $15.91 is -72.16%.
How many employees does XCUR have?
Number of XCUR employees currently stands at 7.
Link for XCUR official website?
Official Website of XCUR is: https://www.exicuretx.com
How do I contact XCUR?
XCUR could be contacted at phone 847 673 1700 and can also be accessed through its website. XCUR operates from 2430 North Halsted Street, Chicago, IL 60614, United States.
How many shares of XCUR are traded daily?
XCUR stock volume for the day was 21.1K shares. The average number of XCUR shares traded daily for last 3 months was 38.96K.
What is the market cap of XCUR currently?
The market value of XCUR currently stands at $28.24M with its latest stock price at $4.43 and 6.37M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep